21 May 2022 - Top doctors have warned that vulnerable patients who test positive to COVID-19 are missing out on ...
25 March 2022 - The utilisation analysis public release documents from the October 2021 DUSC meeting are now available. ...
16 November 2021 - VPAS is a voluntary agreement between the UK government and the Association of the British Pharmaceutical ...
5 November 2021 - The Outcome Statement from the October 2021 Drug Utilisation SubCommittee meeting is now available. ...
9 October 2021 - Pharmacists have raised the alarm over the influence of a US pharmaceutical corporation on Australian doctors ...
6 August 2021 - France has a single payer health insurance system that has the authority to impose pharmaceutical price reductions ...
15 June 2021 - Empagliflozin (with and without metformin hydrochloride) has been funded since 1 February 2021. It is funded for ...
18 May 2021 - The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta ...
19 May 2021 - Almost one-third of adult Australians say they are unlikely to be vaccinated against COVID-19 in a ...
17 May 2021 - New figures show one in four COVID-19 vaccines available in Australia have not been administered, with GP ...
6 May 2021 - Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar ...
28 April 2021 - Australians will not be told how many people have received a second dose of the COVID-19 vaccine ...
18 March 2021 - The utilisation analysis public release documents from the October 2020 Drug Utilisation SubCommittee meeting are now available. ...
10 March 2021 - Australian states and territories have made a secret agreement not to release weekly data to the public ...
15 February 2021 - While apparently non‐inferior to originator biologics, other factors need to be considered before switching ...